openPR Logo
Press release

Pediatric Vaccine Market is expected to reach US$ 38.53 Billion by 2033 | Major Companies - Novartis AG, F. Hoffmann-La Roche AG, Bayer AG, AbbVie.

01-09-2026 06:50 AM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Pediatric Vaccine Market

Pediatric Vaccine Market

Market Overview:

The Global Pediatric Vaccine Market size reached US$ 23.25 Billion in 2024 and is expected to reach US$ 38.53 Billion by 2033, growing at a CAGR of 5.8% during the forecast period 2025-2033.

The Pediatric Vaccine Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/pediatric-vaccines-market?sz

The Pediatric Vaccine Market encompasses the development, production, and distribution of vaccines designed specifically for children to prevent infectious diseases. It includes routine immunizations, combination vaccines, and newly developed vaccines targeting pediatric populations. The market is driven by rising awareness of child health, government immunization programs, technological advancements in vaccine development, and increasing prevalence of preventable childhood diseases.

Recent Key Developments of United States:

✅ November 2025: U.S. efforts focused on integrating advanced vaccine technologies into national immunization programs amid rising child health priorities.

✅ October 2025: Manufacturers expanded multi-dose and combination pediatric vaccines, simplifying vaccination schedules and enhancing compliance in children.

✅ September 2025: Research institutions advanced mRNA-based pediatric vaccines for infectious diseases, accelerating development timelines and regulatory approvals.​

Recent Key Developments of Japan:

✅ November 2025: Japanese pharmaceutical firms introduced pediatric vaccines for influenza, pneumococcal disease, and emerging infectious threats, ensuring safety and high efficacy.​

✅ October 2025: Japan expanded immunization campaigns and vaccination coverage, integrating new pediatric vaccines into national healthcare programs.​

✅ September 2025: Collaborations between Japanese vaccine manufacturers and research institutes targeted novel vaccine platforms and adjuvants to enhance immune response in children.​

List of the Key Players in the Pediatric Vaccine Market:

Novartis AG
Regeneron Pharmaceuticals, Inc.
F. Hoffmann-La Roche AG
Formycon AG
Bayer AG
Alimera Sciences
Knight Therapeutics Inc.
AbbVie
Samsung Bioepis

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/pediatric-vaccines-market?sz

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Pediatric Vaccine Market:

By Disease Type: Infectious Diseases, Allergies.

By Vaccine Type: Monovalent Vaccines, Multivalent Vaccines.

By Technology: Live Attenuated Vaccines, Inactivated Vaccines, Sub-unit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=pediatric-vaccines-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Pediatric Vaccine market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Pediatric Vaccine Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Pediatric Vaccine market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Pediatric Vaccine Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Pediatric Vaccine Market in 2025?
◆ What is the projected growth rate of the Pediatric Vaccine Market through 2033?
◆ Who are the key players in the Pediatric Vaccine Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pediatric Vaccine Market is expected to reach US$ 38.53 Billion by 2033 | Major Companies - Novartis AG, F. Hoffmann-La Roche AG, Bayer AG, AbbVie. here

News-ID: 4341546 • Views:

More Releases from DataM Intelligence 4Market Research

Hydroponics Market is projected to reach USD 47.92 billion by 2032 | Major players - Bright Farms Inc, Kubo Group, Argus Control Systems Limited.
Hydroponics Market is projected to reach USD 47.92 billion by 2032 | Major playe …
Market Size and Growth: The Global Hydroponics Market size reached USD 16.54 billion in 2024 and is projected to reach USD 47.92 billion by 2032, growing at a CAGR of 14.22% during the forecast period 2025-2032. The Hydroponics Market involves the cultivation of plants without soil, using nutrient-rich water solutions. It encompasses systems, equipment, and technologies for commercial and home-based hydroponic farming. Driven by urbanization, water efficiency, and demand for fresh produce,
Hydrogen Compressor Market is expected to reach USD 2.8 billion by 2030 | Major Companies - Ariel Corporation, Corken Compressors, Burckhardt Compression AG, Atlas Copco.
Hydrogen Compressor Market is expected to reach USD 2.8 billion by 2030 | Major …
Market Size and Growth: The Global Hydrogen Compressor Market size reached USD 1.9 billion in 2022 and is expected to reach USD 2.8 billion by 2030, growing with a CAGR of 4.6% during the forecast period 2024-2031. The Hydrogen Compressor Market involves the production, sales, and adoption of compressors designed to store, transport, and distribute hydrogen gas efficiently. These compressors are vital for fueling stations, industrial applications, and energy storage systems,
Surgical Drapes Market is expected to reach US$ 2.74 billion by 2032 | Major players - 3M Company, Medline Industries Inc, Cardinal Health Inc
Surgical Drapes Market is expected to reach US$ 2.74 billion by 2032 | Major pla …
Market Size and Growth: The Global Surgical Drapes Market size reached US$ 1.44 billion in 2024 and is expected to reach US$ 2.74 billion by 2032, growing at a CAGR of 7.4% during the forecast period 2025-2032. The Surgical Drapes Market encompasses the production, distribution, and use of sterile, disposable, or reusable drapes designed to maintain a sterile field during surgical procedures. These drapes protect patients from infection, prevent contamination, and enhance
Gummy Vitamins Market is projected to reach USD 16.2 billion by 2031 | Major Companies - Nature's Bounty Co., Nutramarks Inc., Pfizer Inc, Hero Nutritionals LLC.
Gummy Vitamins Market is projected to reach USD 16.2 billion by 2031 | Major Com …
Market Size and Growth: The Global Gummy Vitamins Market size reached USD 67.3 billion in 2022 and is projected to reach USD 16.2 billion by 2031, growing at a CAGR of 10.5% during the forecast period 2024-2031. The Gummy Vitamins Market refers to the global industry involved in the production, distribution, and sale of chewable, flavored vitamin supplements designed for children and adults. These vitamins offer an alternative to traditional tablets or

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion